No CrossRef data available.
In search of the evidentiary foundation of published Canadian economic evaluations (2001–06)
Published online by Cambridge University Press: 31 March 2009
Abstract
Objectives: The aim of this study was to present a review of economic evaluations conducted from a Canadian perspective and to characterize sources of evidence and statistical methods to analyze effectiveness measures, resource utilization, and uncertainty.
Methods: A search strategy was developed to identify Canadian economic evaluations published between January 2001 and June 2006. A standardized abstraction form was used to extract key data (e.g., study design, data sources, statistical methods).
Results: A total of 153 unique studies were included for review, of which 75 were evaluations of drug therapies and less than half were funded by industry. Cost-effectiveness analysis was the most common type of economic evaluation and 80 percent of the studies used modeling techniques. A single source of evidence for effectiveness measures was used in half of the studies. Statistical methods were commonly reported to compare effectiveness measures when the economic evaluation was conducted alongside a clinical trial but less commonly when determining effectiveness input parameters in model-based economic evaluations, or to analyze resource utilization data. Authors relied mostly on univariate sensitivity analyses to explore uncertainty.
Conclusions: This review identifies the need to improve the conduct and reporting of statistical methods for economic evaluations to improve confidence in the results.
- Type
- General Essays
- Information
- International Journal of Technology Assessment in Health Care , Volume 25 , Issue 2 , April 2009 , pp. 214 - 221
- Copyright
- Copyright © Cambridge University Press 2009
References
REFERENCES
1. Anell, A, Norinder, A. Health outcome measures used in cost-effectiveness studies: A review of original articles published between 1986 and 1996. Health Policy. 2000;51:87–99.Google Scholar
2. Anis, AH, Rahman, T, Schechter, MT. Using pharmacoeconomic analysis to make drug insurance coverage decisions. Pharmacoeconomics. 1998;13:119–126.CrossRefGoogle ScholarPubMed
3. Baladi, JF, Menon, D, Otten, N. Use of economic evaluation guidelines: 2 years' experience in Canada. Health Econ. 1998;7:221–227.3.0.CO;2-N>CrossRefGoogle ScholarPubMed
4. Barber, JA, Thompson, SG. Analysis and interpretation of cost data in randomised controlled trials: Review of published studies. BMJ. 1998;317:1195–1200.CrossRefGoogle ScholarPubMed
5. Briggs, AH. Statistical approaches to handling uncertainty in health economic evaluation. Eur J Gastroenterol Hepatol. 2004;16:551–561.CrossRefGoogle ScholarPubMed
6. Cameron, AC, Trivedi, PK. Regression analysis of count data. Cambridge: Cambridge University Press; 1998.CrossRefGoogle Scholar
7. Canadian Agency for Drug and Technologies in Health (CADTH). Guidelines for the economic evaluation of health technologies. 3rd ed. Ottawa: CADTH; 2006.Google Scholar
8. Canadian Coordinating Office for Health Technology Assessment. Guidelines for economic evaluation of pharmaceuticals: Canada. 1st edition; 1994.Google Scholar
9. Canadian Coordinating Office for Health Technology Assessment. Guidelines for economic evaluation of pharmaceuticals: Canada. 2nd edition; 1997.Google Scholar
10. Claxton, K, Sculpher, M, McCabe, C et al. , Probabilistic sensitivity analysis for NICE technology assessment: Not an optional extra. Health Econ. 2005;14:339–347.CrossRefGoogle ScholarPubMed
11. Cornago, D, Li Bassi, L, De Compadri, P, Garattini, L. Pharmacoeconomic studies in Italy: A critical review of the literature. Eur J Health Econ. 2007;8:89–95.Google Scholar
12. Dalziel, K, Segal, L, Mortimer, D. Review of Australian health economic evaluation – 245 interventions: What can we say about cost effectiveness? Cost Eff Resour Alloc. 2008;6:9.Google Scholar
13. Doshi, JA, Glick, HA, Polsky, D. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials. Value Health. 2006;9:334–340.CrossRefGoogle ScholarPubMed
14. Fenwick, E, Claxton, K, Sculpher, M. Representing uncertainty: The role of cost-effectiveness acceptability curves. Health Econ. 2001;10:779–787.CrossRefGoogle ScholarPubMed
15. Garattini, L, De Compadri, P, Clemente, R, Cornago, D. Economic evaluations in Italy: A review of the literature. Int J Technol Assess Health Care. 2003;19:685–691.Google Scholar
16. Garcia-Altes, A. Twenty years of health care economic analysis in Spain: Are we doing well? Health Econ. 2001;10:715–729.Google Scholar
17. Graves, N, Walker, D, Raine, R et al. , Cost data for individual patients included in clinical studies: No amount of statistical analysis can compensate for inadequate costing methods. Health Econ. 2002;11:735–739.Google Scholar
18. Greene, WH. Econometric analysis. 4th ed. Upper Saddle River, NJ: Prentice Hall; 2000.Google Scholar
19. Hutchinson, MK, Holtman, MC. Analysis of count data using poisson regression. Res Nurs Health. 2005;28:408–418.CrossRefGoogle ScholarPubMed
20. Lee, KS, Brouwer, WBF, Lee, SI, Koo, HW. Introducing economic evaluation as a policy tool in Korea: Will decision makers get quality information? A critical review of published Korean economic evaluations. Pharmacoeconomics. 2005;23:709–721.CrossRefGoogle ScholarPubMed
21. Machado, M, Iskedjian, M, Einarson, TR. Quality assessment of published health economic analyses from South America. Ann Pharmacother. 2006;40:943–949.Google Scholar
22. Nixon, J, Stoykova, B, Glanville, J et al. , The U.K. NHS economic evaluation database. Economic issues in evaluations of health technology. Int J Technol Assess Health Care. 2000;16:731–742.Google Scholar
23. Ramsey, S, Willke, R, Briggs, A et al. , Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA Task Force report. Value Health. 2005;8:521–533.CrossRefGoogle ScholarPubMed
24. Salkeld, G, Davey, P, Arnolda, G. A critical review of health-related economic evaluations in Australia: Implications for health policy. Health Policy. 1995;31:111–125.Google Scholar
25. Schwappach, DL, Boluarte, TA. HEE-GER: A systematic review of German economic evaluations of health care published 1990–2004. BMC Health Serv Res. 2007;7:7.Google Scholar
26. Tarride, JE, McCarron, CE, Lim, M et al. , Economic evaluations conducted by Canadian health technology assessment agencies: Where do we stand? Int J Technol Assess Health Care. 2008;24:437–444.Google Scholar
Tarride supplementary material
Supplementary Figues and tables
File
50.2 KB
Tarride supplementary material
Supplementary figure 1
Image
11.9 KB
Tarride supplementary material
Supplementary figure 2
File
18.4 KB